Cancer News - Topix
Influenced by the president's mandate to "bend the health care cost curve," the Food and Drug Administration is preparing to deny late-stage breast cancer patients access to the critical, but expensive, life-extending drug Avastin.
Sent with Reeder
Sent from my iPad
No comments:
Post a Comment